{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:03:18Z","timestamp":1774609398916,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40493-8","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:05:10Z","timestamp":1771909510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clustering reveals diagnostic overlap between Still\u2019s disease and a hyperinflammatory subset of seronegative rheumatoid arthritis"],"prefix":"10.1038","volume":"16","author":[{"given":"Alexandre","family":"Mercier-Guery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"El-Jammal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"El-Nayef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Massy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrille","family":"Confavreux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvan","family":"Jamilloux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Coury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"40493_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jbspin.2008.05.009","volume":"76","author":"F Hayem","year":"2009","unstructured":"Hayem, F. Is still\u2019s disease an autoinflammatory syndrome? Joint Bone Spine. 76, 7\u20139 (2009).","journal-title":"Joint Bone Spine"},{"key":"40493_CR2","first-page":"28","volume":"32","author":"YJ Kim","year":"2014","unstructured":"Kim, Y. J., Koo, B. S., Kim, Y. G., Lee, C. K. & Yoo, B. Clinical features and prognosis in 82 patients with adult-onset still\u2019s disease. Clin. Exp. Rheumatol. 32, 28\u201333 (2014).","journal-title":"Clin. Exp. Rheumatol."},{"key":"40493_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2025.105872","volume":"92","author":"S Mitrovic","year":"2025","unstructured":"Mitrovic, S. & Fautrel, B. Systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease are the same disease and should now be designated by the same unique name, Still\u2019s disease. Joint Bone Spine 92, 105872 (2025).","journal-title":"Joint Bone Spine"},{"key":"40493_CR4","first-page":"322","volume":"28","author":"B Fautrel","year":"2001","unstructured":"Fautrel, B. et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset still\u2019s disease. J. Rheumatol. 28, 322\u2013329 (2001).","journal-title":"J. Rheumatol."},{"key":"40493_CR5","first-page":"592","volume":"24","author":"KH Nguyen","year":"1997","unstructured":"Nguyen, K. H. & Weisman, M. H. Severe sore throat as a presenting symptom of adult onset Still\u2019s disease: A case series and review of the literature. J. Rheumatol. 24, 592\u2013597 (1997).","journal-title":"J. Rheumatol."},{"key":"40493_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/art.1780300209","volume":"30","author":"JJ Cush","year":"1987","unstructured":"Cush, J. J., Medsger, T. A., Christy, W. C., Herbert, D. C. & Cooperstein, L. A. Adult-onset Still\u2019s disease. Clinical course and outcome. Arthritis Rheum. 30, 186\u2013194 (1987).","journal-title":"Arthritis Rheum."},{"issue":"Suppl 6","key":"40493_CR7","doi-asserted-by":"publisher","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay, J. & Upchurch, K. S. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatol. (Oxford). 51 (Suppl 6), vi5\u20139 (2012).","journal-title":"Rheumatol. (Oxford)"},{"key":"40493_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0889-857X(05)70201-5","volume":"27","author":"SE Gabriel","year":"2001","unstructured":"Gabriel, S. E. The epidemiology of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 27, 269\u2013281 (2001).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"40493_CR9","doi-asserted-by":"publisher","first-page":"e002099","DOI":"10.1136\/rmdopen-2021-002099","volume":"8","author":"L Van Hoovels","year":"2022","unstructured":"Van Hoovels, L. et al. Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein\/peptide antibodies test results. RMD Open. 8, e002099 (2022).","journal-title":"RMD Open."},{"key":"40493_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semarthrit.2010.03.003","volume":"40","author":"JR Curtis","year":"2010","unstructured":"Curtis, J. R. et al. A comparison of patient characteristics and outcomes in selected European and U.S. Rheumatoid arthritis registries. Semin Arthritis Rheum. 40, 2\u201314e1 (2010).","journal-title":"Semin Arthritis Rheum."},{"key":"40493_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/rheumatology\/keaa393","volume":"60","author":"DS Courvoisier","year":"2021","unstructured":"Courvoisier, D. S. et al. The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: Results from a collaboration of 16 registries. Rheumatology (Oxford) 60, 820\u2013828 (2021).","journal-title":"Rheumatology (Oxford)"},{"key":"40493_CR12","first-page":"37","volume":"37","author":"K Paalanen","year":"2019","unstructured":"Paalanen, K. et al. Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study. Clin. Exp. Rheumatol. 37, 37\u201343 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"40493_CR13","first-page":"1055","volume":"61","author":"JM Wouters","year":"1986","unstructured":"Wouters, J. M. & van de Putte, L. B. Adult-onset Still\u2019s disease; clinical and laboratory features, treatment and progress of 45 cases. Q. J. Med. 61, 1055\u20131065 (1986).","journal-title":"Q. J. Med."},{"key":"40493_CR14","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/acr.22194","volume":"66","author":"H Ichida","year":"2014","unstructured":"Ichida, H. et al. Clinical manifestations of adult-onset Still\u2019s disease presenting with erosive arthritis: Association with low levels of ferritin and interleukin-18. Arthritis Care Res. (Hoboken) 66, 642\u2013646 (2014).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"40493_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226703","volume":"11","author":"P-A Neau","year":"2022","unstructured":"Neau, P.-A. et al. The spectrum of Still\u2019s disease: A comparative analysis of phenotypic forms in a cohort of 238 patients. J. Clin. Med. 11, 6703 (2022).","journal-title":"J. Clin. Med."},{"key":"40493_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","volume":"81","author":"B Fautrel","year":"2002","unstructured":"Fautrel, B. et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 81, 194\u2013200 (2002).","journal-title":"Medicine (Baltimore)"},{"key":"40493_CR17","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi, M. et al. Preliminary criteria for classification of adult still\u2019s disease. J. Rheumatol. 19, 424\u2013430 (1992).","journal-title":"J. Rheumatol."},{"key":"40493_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12016-021-08890-1","volume":"63","author":"MV Sokolova","year":"2022","unstructured":"Sokolova, M. V., Schett, G. & Steffen, U. Autoantibodies in rheumatoid arthritis: Historical background and novel findings. Clin. Rev. Allergy Immunol. 63, 138\u2013151 (2022).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"40493_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/1354750X.2020.1794043","volume":"26","author":"B Kolarz","year":"2021","unstructured":"Kolarz, B., Podgorska, D. & Podgorski, R. Insights of rheumatoid arthritis biomarkers. Biomarkers 26, 185\u2013195 (2021).","journal-title":"Biomarkers"},{"key":"40493_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2024.105800","volume":"92","author":"S Bugatti","year":"2025","unstructured":"Bugatti, S. & Montecucco, C. Seronegative rheumatoid arthritis: Neglected in clinical trials, a giant in clinical practice. Joint Bone Spine 92, 105800 (2025).","journal-title":"Joint Bone Spine"},{"key":"40493_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/imr.12829","volume":"294","author":"M Volkov","year":"2020","unstructured":"Volkov, M., van Schie, K. A. & van der Woude, D. Autoantibodies and B cells: The ABC of rheumatoid arthritis pathophysiology. Immunol. Rev. 294, 148\u2013163 (2020).","journal-title":"Immunol. Rev."},{"key":"40493_CR22","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1093\/rheumatology\/keab838","volume":"61","author":"P Sidiras","year":"2022","unstructured":"Sidiras, P. et al. Human carbamylome description identifies carbamylated \u03b12-macroglobulin and hemopexin as two novel autoantigens in early rheumatoid arthritis. Rheumatology (Oxford) 61, 2826\u20132834 (2022).","journal-title":"Rheumatology (Oxford)"},{"key":"40493_CR23","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1093\/rheumatology\/keaa904","volume":"60","author":"O Berardicurti","year":"2021","unstructured":"Berardicurti, O. et al. Dissecting the clinical heterogeneity of adult-onset Still\u2019s disease: Results from a multi-dimensional characterization and stratification. Rheumatology (Oxford) 60, 4844\u20134849 (2021).","journal-title":"Rheumatology (Oxford)"},{"key":"40493_CR24","doi-asserted-by":"publisher","first-page":"e003419","DOI":"10.1136\/rmdopen-2023-003419","volume":"9","author":"P Ruscitti","year":"2023","unstructured":"Ruscitti, P. et al. Derivation and validation of four patient clusters in still\u2019s disease, results from GIRRCS AOSD-study group and AIDA network still disease registry. RMD Open. 9, e003419 (2023).","journal-title":"RMD Open."},{"key":"40493_CR25","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00296-011-1801-6","volume":"32","author":"H-A Kim","year":"2012","unstructured":"Kim, H.-A., Sung, J.-M. & Suh, C.-H. Therapeutic responses and prognosis in adult-onset Still\u2019s disease. Rheumatol. Int. 32, 1291\u20131298 (2012).","journal-title":"Rheumatol. Int."},{"key":"40493_CR26","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-2171","volume":"10","author":"D Lin","year":"2022","unstructured":"Lin, D. et al. Seronegative rheumatic arthritis has milder inflammation and bone erosion in an ultrasound study of disease-modifying anti-rheumatic drugs (DMARDs)-na\u00efve Chinese cohort. Ann. Transl. Med. 10, 661 (2022).","journal-title":"Ann. Transl. Med."},{"key":"40493_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.978351","volume":"9","author":"N Carbonell-Bobadilla","year":"2022","unstructured":"Carbonell-Bobadilla, N. et al. Patients with seronegative rheumatoid arthritis have a different phenotype than seropositive patients: A clinical and ultrasound study. Front. Med. 9, 978351 (2022).","journal-title":"Front. Med."},{"key":"40493_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040465","volume":"11","author":"H Kamiya","year":"2021","unstructured":"Kamiya, H. & Panlaqui, O. M. Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody. BMJ Open 11, e040465 (2021).","journal-title":"BMJ Open"},{"key":"40493_CR29","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3899\/jrheum.170437","volume":"45","author":"C Caimmi","year":"2018","unstructured":"Caimmi, C., Crowson, C. S., Smith, W. M., Matteson, E. L. & Makol, A. Clinical correlates, outcomes, and predictors of inflammatory ocular disease associated with rheumatoid arthritis in the biologic era. J. Rheumatol. 45, 595\u2013603 (2018).","journal-title":"J. Rheumatol."},{"key":"40493_CR30","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s00330-018-5755-x","volume":"29","author":"M Koslow","year":"2019","unstructured":"Koslow, M. et al. Rheumatoid pulmonary nodules: Clinical and imaging features compared with malignancy. Eur. Radiol. 29, 1684\u20131692 (2019).","journal-title":"Eur. Radiol."},{"key":"40493_CR31","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.3899\/jrheum.140082","volume":"41","author":"L Barra","year":"2014","unstructured":"Barra, L. et al. Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis. J. Rheumatol. 41, 2361\u20132369 (2014).","journal-title":"J. Rheumatol."},{"key":"40493_CR32","doi-asserted-by":"crossref","unstructured":"Aletaha, D. et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62, 2569\u20132581 (2010). (2010).","DOI":"10.1002\/art.27584"},{"key":"40493_CR33","doi-asserted-by":"crossref","unstructured":"Boeters, D. M., Gaujoux-Viala, C., Constantin, A. & van der Helm-van Mil, A. H. M. The 2010 ACR\/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: Results from the Leiden-EAC and ESPOIR cohorts. Semin Arthritis Rheum. 47, 170\u2013174 (2017).","DOI":"10.1016\/j.semarthrit.2017.04.009"},{"key":"40493_CR34","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/cells13090743","volume":"13","author":"J Perera","year":"2024","unstructured":"Perera, J., Delrosso, C. A., Nerviani, A. & Pitzalis, C. Clinical phenotypes, serological biomarkers, and synovial features defining seropositive and seronegative rheumatoid arthritis: A literature review. Cells 13, 743 (2024).","journal-title":"Cells"},{"key":"40493_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000752","volume":"4","author":"LB Nordberg","year":"2018","unstructured":"Nordberg, L. B. et al. Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR\/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial. RMD Open 4, e000752 (2018).","journal-title":"RMD Open"},{"key":"40493_CR36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/annrheumdis-2015-207942","volume":"75","author":"J Sokolove","year":"2016","unstructured":"Sokolove, J. et al. Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial. Ann. Rheum. Dis. 75, 709\u2013714 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"40493_CR37","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/annrheumdis-2020-217725","volume":"79","author":"M Greenwood","year":"2020","unstructured":"Greenwood, M. et al. Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive. Ann. Rheum. Dis. 79, 1516\u20131517 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"40493_CR38","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/ard.2003.016014","volume":"63","author":"SB Cohen","year":"2004","unstructured":"Cohen, S. B. et al. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Ann. Rheum. Dis. 63, 1062\u20131068 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"40493_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/acr.20319","volume":"63","author":"X Pu\u00e9chal","year":"2011","unstructured":"Pu\u00e9chal, X. et al. Tocilizumab in refractory adult Still\u2019s disease. Arthritis Care Res. (Hoboken) 63, 155\u2013159 (2011).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"40493_CR40","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/art.23940","volume":"58","author":"MC Genovese","year":"2008","unstructured":"Genovese, M. C. et al. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis Rheum. 58, 2968\u20132980 (2008).","journal-title":"Arthritis Rheum."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40493-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40493-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40493-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T10:09:47Z","timestamp":1774606187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40493-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40493"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40493-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10339"}}